In focus
Latest feed
The Shifting Tides: A Breakthrough and a Retreat in the Battle Against Chronic Cough
Unpacking Newron's Q4 2023: A Closer Look at Evenamide's Journey and Financial Health
Dogwood Therapeutics Charts Ambitious Course Amidst Significant 2025 Investments
A Setback for Moderna's mRNA Flu Vaccine Aspirations
